SUN Pharmaceutical Industries Limited Temozolomide Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Temozolomide Export Records India — #1 Exporter, 311 Shipments, $14.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Temozolomide

India Pharmaceutical Trade Intelligence

$23.5M133 Suppliers90 CountriesHS 30049049

ExportsIndia → CANADA31.8%India → BELGIUM22.5%

ImportsBELGIUM → India$34.4K NETHERLANDS → India$30.5K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

SUN Pharmaceutical Industries Limited — Temozolomide Exporter #1 | $15.6M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Temozolomide Exporter Profile

Indian Pharmaceutical Exporter · #1 for Temozolomide · $15.6M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Temozolomide with $15.6M in export value and 311 verified shipments. SUN Pharmaceutical Industries Limited holds a 62.4% market share in Temozolomide exports across 8 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Temozolomide Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Temozolomide export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Temozolomide?

Country	Value	Shipments	Share
BELGIUM	$4.3M	207	57.2%
CANADA	$1.4M	28	18.0%
BRAZIL	$654.6K	18	8.7%
COLOMBIA	$434.5K	11

Who Are the Top Buyers of Temozolomide from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$3.8M	184
TARO PHARMACEUTICALS INC.,	CANADA	$590.9K	12
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$493.4K	23
TARO PHARMACEUTICALS INC	CANADA	$420.0K	9
LABORATORIOS LA SANTE S.A.	COLOMBIA	$256.5K	7
TARO PHARMACEUTICALS INC.	CANADA	$250.0K	5
M/S	COLOMBIA	$239.1K	7
SUN PHARMA PHILIPPINES INC.	PHILIPPINES	$216.8K	7
M/S. SUN FARMACEUTICA DO BRAZIL LTD	BRAZIL	$204.0K	5
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$146.5K	19

SUN Pharmaceutical Industries Limited supplies Temozolomide to 28 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by TARO PHARMACEUTICALS INC., (CANADA) and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Temozolomide Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
TARO-TEMOZOLOMIDE 20MG CAPSULES [8050 PACK X 1X5] BATCH NO. HAF0556A MFG. DT. 03/2024 EXP. DT. 02/2026	$150.0K	3
TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5] BATCH NO. HAF0558A & HAF0559A MFG. DT. 02/2024 EXP. DT. 01/2026	$150.0K	3
TARO-TEMOZOLOMIDE 140MG CAPSULES [8307 PACK X 1X5] BATCH NO. HAF0730A & HAF0731AMFG DT: 03/2024 EXP DT: 02/2026	$150.0K	3
TEMOZOLOMIDE SUN CAP 250MG 1x5B HU PACK	$144.0K	3
TARO-TEMOZOLOMIDE 5MG CAPSULES [25247 PACK X 1X5] BATCH NO. HAF0382B MFG. DT. 02/2024 EXP. DT. 01/2026	$140.9K	3
TEMOZOLOMIDE SUN CAP 140MG 1x5B GB PACK	$101.7K	4
TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :	$100.0K	2
TEMOZOLOMIDE SUN CAP 100MG 1x5B HU PACK	$100.0K	2
TARO-TEMOZOLOMIDE 20MG CAPSULES (8564 PACK X 1X5) (BATCH NO. HAF3045A MFG DT. 01/2025 EXP DT. 12/2026)	$100.0K	2
TEMOZOLOMIDE SUN CAP 100MG 1x5B IT PACK	$96.8K	4

SUN Pharmaceutical Industries Limited exports 265 distinct Temozolomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TARO-TEMOZOLOMIDE 20MG CAPSULES [8050 PACK X 1X5] BATCH NO. with 3 shipments worth $150.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Temozolomide Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$14.7M	311	8	$47.1K
3	JODAS EXPOIM PRIVATE LIMITED	$1.8M	35	5	$50.0K
4	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$1.7M	100	14	$16.7K

SUN Pharmaceutical Industries Limited ranks #1 among 133 Indian Temozolomide exporters. Average shipment value of $47.1K compared to the market average of $163.4K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Temozolomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	247	19.6%
SAHAR AIR	221	17.5%
NHAVA SHEVA SEA (INNSA1)	112	8.9%
DELHI AIR CARGO ACC (INDEL4)	99	7.9%
DELHI AIR	72	5.7%
JNPT/ NHAVA SHEVA SEA	53	4.2%
Bombay Air	51	4.0%
HYDERABAD ACC (INHYD4)	50	4.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Temozolomide Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Temozolomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 330 individual customs records matching SUN Pharmaceutical Industries Limited exporting Temozolomide, covering 265 formulations to 8 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 90+ countries, 250+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Temozolomide

Temozolomide

SUN Pharmaceutical Industries Limited — Temozolomide Exporter Profile

SUN Pharmaceutical Industries Limited — Temozolomide Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Temozolomide?

Who Are the Top Buyers of Temozolomide from SUN Pharmaceutical Industries Limited?

What Is India's Total Temozolomide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Temozolomide Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Temozolomide Exporters?

What Temozolomide Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Temozolomide to Key Markets

Canada — HC

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Temozolomide Exporters?

Which Indian Ports Ship Temozolomide Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Temozolomide Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Temozolomide Export Data from SUN Pharmaceutical Industries Limited

Temozolomide Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source